You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 67 No. 1, January 2010 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 •eTable
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Neurology
 •Alzheimer Disease
 •Cognitive Disorders
 •Dementias
 •Neurogenetics
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Association of C-Reactive Protein With Cognitive Impairment

James M. Noble, MD, MS; Jennifer J. Manly, PhD; Nicole Schupf, PhD; Ming Xing Tang, PhD; Richard Mayeux, MD, MS; José A. Luchsinger, MD, MPH

Arch Neurol. 2010;67(1):87-92.

Background  High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.

Objective  To explore the association between hsCRP and cognitive impairment.

Design  Cross-sectional analysis of a population-based community aging study.

Setting  Northern Manhattan, New York, New York.

Other Participants  One thousand three hundred thirty-one participants from a longitudinal study of aging without dementia and with available hsCRP and neuropsychological testing data at baseline.

Main Outcome Measures  Four cognitive scores (memory, visuospatial, executive, and language impairment) derived from a neuropsychological battery. Cognitive impairment was defined by scores below 1.5 SDs of demographically corrected means.

Results  Participants in the highest hsCRP tertile had higher adjusted odds of impaired memory (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.0-2.1; P = .03) than participants in the lowest tertile. Subjects in the highest hsCRP tertile also had greater odds of visuospatial impairment (OR, 1.6; 95% CI, 1.0-2.3; P = .03). Higher hsCRP was not associated with executive or language impairment. Persons with at least 1 APOE {varepsilon}4 allele and hsCRP in the highest tertile had the greatest odds of impaired memory (OR, 2.7; 95% CI, 1.6-4.4).

Conclusions  High hsCRP may be a marker of memory and visuospatial impairment in the elderly. The role of APOE {varepsilon}4 requires further exploration.


Author Affiliations: Gertrude H. Sergievsky Center, Columbia University (Drs Noble, Manly, Schupf, Tang, Mayeux, and Luchsinger); Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University (Drs Noble, Manly, Schupf, Mayeux, and Luchsinger); Departments of Neurology (Drs Noble and Mayeux) and Psychiatry (Dr Mayeux), and Division of General Medicine, Department of Medicine (Dr Luchsinger), Columbia University College of Physicians and Surgeons; and Departments of Epidemiology (Drs Schupf, Mayeux, and Luchsinger) and Biostatistics (Dr Tang), Joseph P. Mailman School of Public Health, Columbia University, New York, New York.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2010;67(1):13-14.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study
van Himbergen et al.
Arch Neurol 2012;0:archneurol.2011.670v1-7.
ABSTRACT | FULL TEXT  

Cognitive dysfunction with aging and the role of inflammation
Simen et al.
Therapeutic Advances in Chronic Disease 2011;2:175-195.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2010 American Medical Association. All Rights Reserved.